Morgan Stanley Maintains Equal-Weight on HashiCorp, Lowers Price Target to $37

Morgan Stanley analyst Sanjit Singh maintains HashiCorp (NASDAQ:HCP) with a Equal-Weight and lowers the price target from $40 to $37.

byBenzinga Newsdesk

December 19, 2022

1 minute read

Morgan Stanley analyst Sanjit Singh maintains HashiCorp (NASDAQ:HCP) with a Equal-Weight and lowers the price target from $40 to $37.

Pingtan Marine Enterprise Reports Q4 2021 Revenue $62.8M; EPS $(1.00)

By Benzinga Newsdesk

May 17, 4:47 PM

Pingtan Marine Enterprise Ltd. (NASDAQ:PME) ("Pingtan" or the "Company"), a fishing company based in the People's Republic of China (PRC), today announced financial results for

PME

PleasrDAO Aint Nothing To F*** With: Wu Tang Clan Album Once Owned By Shkreli Has Been Purchased

By Chris Katje

October 22, 10:22 AM

From the slums of Shaolin, Wu-Tang Clan strikes again. An exclusive album made by the legendary hip-hop group is back in the news with the latest anonymous buyer of the album being revealed earlier this week.

$DOGE

RBC Capital Downgrades Doman Building Materials to Sector Perform, Lowers Price Target to C$7

By Benzinga Newsdesk

July 18, 7:31 AM

RBC Capital analyst Paul Quinn downgrades Doman Building Materials (TSX:DBM) from Outperform to Sector Perform and lowers the price target from C$10 to C$7.

TSX:DBM

From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers

By Fermin Orgambide

April 4, 8:51 PM

With over ten years of experience in the pharmaceutical industry, Robert Barrow, CEO of Mind Medicine Inc. (NASDAQ:MNMD)…

MNMD

Morgan Stanley Maintains Equal-Weight on HashiCorp, Lowers Price Target to $37

Related Posts

Pingtan Marine Enterprise Reports Q4 2021 Revenue $62.8M; EPS $(1.00)

PleasrDAO Aint Nothing To F*** With: Wu Tang Clan Album Once Owned By Shkreli Has Been Purchased

RBC Capital Downgrades Doman Building Materials to Sector Perform, Lowers Price Target to C$7

From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers